2018: Schweikert Voted For An FY 2019 Conference Report Minibus Spending Bill And Continuing Resolution That Appropriated $39.1 Billion For The NIH. In September 2018, Schweikert voted for an FY 2019 Labor, HHS, Education, and Defense minibus spending bill conference report. According to Congressional Quarterly, "Adoption of the conference report on the bill that would provide $855.1 billion in discretionary funding for fiscal 2019 to various departments and agencies, including $674.4 billion for the Defense Department and $178.1 billion for the Labor, Health and Human Services and Education departments. The Defense Department total would include $606.5 billion in base Defense Department funding subject to spending caps, and would include $67.9 billion in overseas contingency operations funding. The bill would provide $90.3 billion in discretionary spending for the Health and Human Services Department, $71.4 billion for the Education Department and $12.1 billion for the Labor Department. The measure would also provide funding for federal government operations until Dec. 7, 2018, at an annualized rate of approximately $1.3 trillion." The vote was on passage. The House passed the bill by a vote of 361 to 61. The president later signed the bill into law. [House Vote 405, 9/26/18; Congressional Quarterly, 9/26/18; Congressional Actions, H.R. 6157]
2018: Schweikert Voted Against The $1.3 Trillion FY 2018 Omnibus Spending Deal Which Raised Spending By $138 Billion Over FY 2017 Levels, Including A $3.0 Billion Increase In NIH Funding. In March 2018, Schweikert voted against the FY 2018 Omnibus spending bill. According to Congressional Quarterly, "Combined, the spending measures would provide about $1.3 trillion in discretionary spending, with $1.2 trillion subject to discretionary spending caps, and $78.1 billion designated as Overseas Contingency Operations funds. The measure's spending levels are consistent with the increased defense and non-defense budget caps set by the two-year budget deal agreed to last month. That agreement increased the FY 2018 defense cap by $80 billion and the non-defense cap by $63 billion. Given that the previous caps were set to reduce overall discretionary spending by $5 billion, the net increase provided by the omnibus is $138 billion over the FY 2017 level." The vote was on the motion to concur in the Senate Amendment with an Amendment. The House agreed to the motion, thereby passing the bill, by a vote of 256 to 167. The Senate later agreed to the legislation, sending it to the president, who signed it into law. [House Vote 127, 3/22/18; Congressional Quarterly, 3/22/18; Congressional Actions, H.R. 1625]
2018: Schweikert Voted Against A February 2018 Two-Year Budget Deal Which, Among Other Things, Increased Spending By $300 Billion, Suspended The Debt Ceiling, Reauthorized Community Health Centers For Two Years And Provided $2 Billion In NIH Funding. In February 2018, Schweikert voted against a two-year budget deal that re-opened the government after a brief shutdown. According to the New York Times, "With Mr. Trump's signature, the government will reopen before many Americans were aware it had closed, with a deal that includes about $300 billion in additional funds over two years for military and nonmilitary programs, almost $90 billion in disaster relief in response to last year's hurricanes and wildfires, and a higher statutory debt ceiling." In addition, according to Congressional Quarterly, the legislation "would provide funding for federal government operations and services at current levels through March 23, 2018 [...] [and] retroactively extends numerous tax breaks that expired at the end of 2016. It also extends the CHIP program for another four years (through FY 2027) and funds community health centers for another two years." The vote was on a motion to concur in the Senate amendment to the House amendment to the bill. The House agreed to the motion, essentially on passage, by a vote of 240 to 186. The bill was then sent to the president, who signed it into law. [House Vote 69, 2/9/18; New York Times, 2/8/18; Congressional Quarterly, 2/9/18; Congressional Actions, H.R. 1892]
2017: Schweikert Voted Against The May 2017 FY 2017 Omnibus Appropriations Bill That Increased Funding For The NIH By $2 Billion. In May 2017, Schweikert voted against the FY 2017 omnibus appropriations bill that would keep much of the government open and would have provided $1.16 trillion in discretionary spending. According to Congressional Quarterly, "The measure provide[d] $34.1 billion for the National Institutes of Health (NIH), $2 billion (6%) more than the FY 2016 level and $3 million (10%) more than requested. It increase[d] for all NIH research programs, including those related to Alzheimer's disease, antibiotics and the Precision Medicine initiative." Overall, the legislation would have, according to Congressional Quarterly, "provide[d] $1.16 trillion in discretionary appropriations through Sept. 30, 2017 for federal departments and agencies covered by the remaining 11 fiscal 2017 spending bills. [...] The measure would also [have] provide[d] $608 million for health benefits for retired coal miners, $296 million for Medicaid payments to Puerto Rico, and $341 million to replace 40 miles of existing fencing along the southwestern border, though the designs of the fencing must have been 'previously deployed'." The vote was on a motion to concur in the Senate amendments. The House agreed to the motion by a vote of 309 to 118. The Senate later also agreed to the legislation, sending the bill to the president, who signed it into law. [House Vote 249, 5/3/17; Roll Call, 5/2/17; Congressional Quarterly, 5/2/17; Congressional Quarterly, 5/4/17; Congressional Actions, H.R. 244]
2015: Schweikert Voted Against Providing A Seven Percent Increase For National Institutes Of Health (NIH) Funding As Part Of The FY 2016 Omnibus. In December 2015, Schweikert voted against funding the NIH at an increased level. According to Congressional Quarterly, "The measure provides $32.1 billion for the National Institutes of Health (NIH), $2 billion (7%) more than the FY 2015 level and $1 million (3%) more than requested." The legislation was, according to Congressional Quarterly, a FY 2016 Omnibus Appropriations bill. The vote was on a motion to concur in the Senate amendment to the bill with an amendment. The House agreed to the motion by a vote of 316 to 113. The legislation was later combined with a tax extender bill. The Senate passed the larger measure and the president signed it. [House Vote 705, 12/18/15; Congressional Quarterly, 12/18/15; Congressional Quarterly, 12/15/15; Congressional Quarterly, 12/17/15; Congressional Actions, H.R. 2029]
2015: Schweikert Voted To Reauthorize The NIH For Three Years And Providing It Nearly $100 Billion In Discretionary Funding As Part Of A Larger Medical Funding Bill. In July 2015, Schweikert voted for legislation that would have, according to Congressional Quarterly, "modif[ied] current federal processes involving medical research, developing drugs and other treatments, and testing and approving those drugs and treatments in an effort to accelerate the development and delivery of cures to diseases and medical conditions. It would [have] also reauthorize[d] the National Institutes of Health (NIH) for three years and includes numerous initiatives to promote medical research and attract young scientists, and it reauthorizes Food and Drug Administration (FDA) activities for five years and modifies elements of FDA's drug and medical device review and approval process to accelerate the approval and distribution of new drugs and medical devices for diseases and conditions that don't currently have treatments." The vote was on the legislation. The House approved the bill by a vote of 344 to 77. A separate, but related bill later became law. [House Vote 433, 7/10/15; Congressional Quarterly, 7/8/15; Congressional Quarterly, 7/10/15; Congressional Actions, H.R. 34; Congressional Actions, H.R. 6]
2015: Schweikert Voted To Make The Underlying Legislation's National Institutes Of Health And Cures Innovation Fund Discretionary Spending Instead Of Mandatory. In July 2015, Schweikert voted for an amendment that would have, according to Congressional Quarterly, "change[d] the mandatory funding for the new National Institute of Health and Cures Innovation Fund to an authorization of discretionary appropriations." According to Congressional Quarterly, the underlying legislation "provide[d] for a five-year 'NIH & Cures Innovation Fund' to be created within the Treasury that would be used for NIH biomedical research and FDA Cures development activities, with the NIH to receive $1.75 billion from the fund each fiscal year from 2016 through 2020 and the FDA to receive $110 million each year. Those amounts would be in addition to regular discretionary funding provided through the appropriations process." The underlying legislation was the 21st Century Cures Act, which was a medical funding and authorizing act. The vote was on the amendment. The House rejected the amendment by a vote of 141 to 281. [House Vote 431, 7/10/15; Congressional Quarterly, 7/10/15; Congressional Quarterly, 7/8/15; Congressional Actions, H. Amdt. 656; Congressional Actions, H.R. 6]
2014: Schweikert Voted Against Funding The NIH At $30.1 Billion, $150 Million More Than FY 2014, Including $238 Million For Ebola, As Part Of Legislation Providing FY 2015 Funding For The Rest Of The Government. In December 2014, Schweikert voted against House-passed legislation that, according to Congressional Quarterly, "finance[d] government operations through Sept. 30 [2015], the remainder of FY 2015, through full, detailed, annual appropriations bills for all spending measures except Homeland Security --- which would be funded by a continuing resolution until Feb. 27." According to Congressional Quarterly, the legislation "provides $30.1 billion for the National Institutes of Health (NIH), $150 million (0.5%) more than the FY 2014 level and $50 million (less than 1%) less than The vote was on a motion to concur in the Senate Amendment with an Amendment. The House agreed to the motion 219 to 206. The Senate agreed to by a vote of 56 to 40. Afterwards, the amended legislation was sent to the president, who signed it into law. [House Vote 563, 12/11/14; Congressional Quarterly, 12/10/14; Congressional Actions, H.R. 83; Public Law, 113-235]